Pharmacogenetics may influence tacrolimus daily dose, but not urinary tubular damage markers in the long-term period after renal transplantation

Por Stefanović Nikola Z., Cvetković Tatjana P., Veličković-Radovanović Radmila M., Jevtović-Stoimenov Tatjana M., Vlahović Predrag M., Stojanović Ivana R., Pavlović Dušica D.
Publicado em 2015-01-01

Pharmacogenetics may Influence Tacrolimus Daily Dose, but not Urinary Tubular Damage Markers in the Long-Term Period after Renal Transplantation

Por Stefanović, Nikola Z., Cvetković, Tatjana P., Veličković-Radovanović, Radmila M., Jevtović-Stoimenov, Tatjana M., Vlahović, Predrag M., Stojanović, Ivana R., Pavlović, Dušica D.
Publicado no J Med Biochem (2015)

How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients

Por Dimitrijevic, Zorica M., Cvetkovic, Tatjana P., Djordjevic, Vidojko M., Pavlovic, Dusica D., Stefanovic, Nikola Z., Stojanovic, Ivana R., Paunovic, Goran J., Velickovic-Radovanovic, Radmila M.
Publicado em 2012